Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
... announced today that it is expanding its clinical pharmacology
footprint in Europe with the acquisition of Swiss ... clients' need for complex, high-science clinical pharmacology
studies that can help them make decisions faster ... includes a modern, well-equipped clinical pharmacology
facility that will increase Covance's global ...
Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
... reputation among the regulatory and clinical pharmacology
community in the U.S. and China. These ... experience at U.S. FDA. Derek was Senior Clinical pharmacology
Reviewer in the Office of Clinical Pharmacology, ... and he has extensive experience in clinical pharmacology
drug development plans/strategies and regulatory ...
Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
... was an assistant professor in the department of pharmacology
at the University of North Carolina at Chapel Hill .
Dr. Lai earned a Ph.D. in pharmacology
and microbiology from Columbia University , M. Phil. and M.A. degrees from the department of pharmacology
at Columbia, and a B.S. in chemistry from the ...
PAREXEL Expands Pioneering Asian Ethnobridging Expertise
... has collaborated with PAREXEL's
experts to establish a high standard for conducting
studies outside of Japan. PAREXEL has completed ... on ethnobridging studies.
PAREXEL's clinical pharmacology
services support numerous therapeutic
Aureus Pharma Releases New Unified Knowledge Database
... AurSCOPE(R) Global pharmacology
Space and Drug Target Knowledge Databases ... as the centralized
product AurSCOPE(R) Global pharmacology
Space (AurSCOPE(R) GPS). AurSCOPE
GPS comprises ... pipeline.
"The release of AurSCOPE Global pharmacology
Space (GPS), Nuclear
Receptor and Protease ...
deCODE genetics Announces Second Quarter 2008 Financial Results
... of the year reflects the
conclusion of clinical pharmacology
studies in our most advanced drug
development ... infrastructure. Through small,
studies like that we recently completed ... positive
topline results from its latest clinical pharmacology
study of DG041, the
company's first-in-class ...
PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
... PAREXEL. "Our global team of clinical pharmacology
with in-depth CNS expertise applies ... area of research."
PAREXEL's dedicated clinical pharmacology
services directed at
alleviation of pain and ... and cost savings for clients.
PAREXEL's clinical pharmacology
business has more than 550 beds, among ...
PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
... been appointed as Vice Presidents
of Clinical pharmacology
Consulting Services in the Company's international
business. These leading experts advise clients ... Dr.
Ereshefsky is based at PAREXEL's Clinical pharmacology
Research Unit in Los
Angeles, California in the ...
PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
... minority interest ownership in the clinical pharmacology
Synchron Research in Ahmedabad, ... PAREXEL has developed a strong global
capability, through both organic growth ... increased investment
in Synchron's clinical pharmacology
business demonstrates our commitment to
Tianyin Pharmaceutical Appoints Three New Independent Board Members
Pharmacological Society and the Clinical pharmacology
Committee of Shaanxi
Pharmaceutical Association. ... his Bachelor of Pharmacy and
Master's degree in pharmacology
of Traditional Chinese Medicine from
Shaanxi ... Chinese Medicine. He earned his Ph.D.
degree in pharmacology
of Traditional Chinese Medicine from ...
Medpace Hires Clinical Pharmacologist, Jim Wei, MD, PhD
... as a Senior
Reviewer in the Office of Clinical pharmacology
for almost 10 years. He was
heavily involved in ... Cancer Institute, a Fellow in the Clinical pharmacology
the Veteran Affairs Medical Center in ... the Division of Cardiology and Clinical pharmacology
at the Zhejiang
Medical University Hospital in ...
Pharsight Expands Strategic Consulting Services Team
... also served as a lecturer in the
Department of pharmacology
at the University of Auckland in New ... and has completed
coursework for his Ph.D. in pharmacology
and Clinical pharmacology
University of Auckland. Mr. Monteleone ...
Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
... with high-content image analysis, hit-to-probe chemistry, exploratory pharmacology
expertise, and informatics, provides a technology platform that is ... Gregory Roth, associate professor and director of medicinal chemistry and pharmacology
Magellan BioScience Group, Inc., based ...
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
... Solomon Snyder, M.D., distinguished service professor of Neuroscience, pharmacology
and Psychiatry, Johns Hopkins School of Medicine and chairman of The Dr. ... Snyder, M.D., (chairman) distinguished service professor of Neuroscience, pharmacology
and Psychiatry, Johns Hopkins School of Medicine ; co-winner, 1978 Albert ...
Covance to Present at the Drug Information Association's 45th Annual Meeting
... | Poster Presentation: Jackie Miller-Giles, MT (ASCP), MS, global clinical pharmacology
"Nonclinical Support for First-in-Human Clinical ... Mary Westrick, PhD, global vice president and general manager, clinical pharmacology
June 24, 2009:
"Six Sigma: How to Leverage 'A ...
Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity
... -- Teva Neuroscience, Inc. today presented results from a clinical pharmacology
study in which AZILECT(R) (rasagiline tablets) did not increase the risk ... and therefore a selectivity for MAO-B inhibition."
The clinical pharmacology
trial was a double-blind, placebo-controlled, randomized, dose-ranging ...
Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress
The first poster presented data on the pharmacokinetics and pharmacology
of CPX-351 from a Phase I study of patients with relapsed or refractory ... List of abstracts:
Feldman E, Lancet J, Kolitz JE, et al. pharmacology
of CPX-351: a nano-scale liposomal fixed molar ratio ...
Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
... segment includes preclinical toxicology, analytical chemistry, clinical pharmacology
services, and research products. Early Development net revenues for the ... Chandler, and costs incurred for the consolidation of two small clinical pharmacology
sites. In addition, the company maintained staffing levels to support ...
Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
... quality. Improvement in these sleep parameters is driven by the unique pharmacology
of ITI-007 that can act simultaneously as a 5HT2A receptor antagonist, ... 5HT2A receptor antagonists and may be attributed to additional beneficial pharmacology
that emerges at the higher doses tested. The highest dose tested (10 mg) ...
PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
... safe and effective
treatments to the market."
"Our global clinical pharmacology
team worked with Glenmark to develop
an innovative way to accelerate ... Middle, MB ChB, Corporate Vice
President and Worldwide Head of Clinical pharmacology
at PAREXEL. "We are
honored to receive this award in partnership with ...
Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program
... and specificity. These lead
compounds are currently being assessed in pharmacology
and toxicology in
order to determine if one is suitable for clinical ... of compounds in preclinical models of disease and
the completion of the pharmacology
and toxicology. The FARA and NAF grant
will support the development of new ...
ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
... meeting of its Advisory Committee for Pharmaceutical
Science and Clinical pharmacology
is not intended to discuss specifically
ViroPharma's Vancocin(R) ... meeting of the Advisory Committee for
Pharmaceutical Science and Clinical pharmacology
is not intended to discuss
specifically ViroPharma's Vancocin(R) and that ...
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
... most recently as Senior Director, Regulatory Affairs. He
earned a Ph.D. in pharmacology
from University College London (funded by
the Sandoz Institute for Medical ... (now Novartis AG) from 2005 to
2006, where she led the clinical pharmacology
pharmokinetics (PK)/drug metabolism group, supporting the ...
Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
... to Solomon Snyder, Ph.D., Distinguished Service Professor of
and Psychiatry, Johns Hopkins School of Medicine
and Chairman, Janssen ... Ph.D., (chairman) Distinguished Service Professor of Neuroscience, pharmacology
and Psychiatry, Johns Hopkins School of Medicine; co-winner, 1978 ...
deCODE Genetics Announces Full-year 2007 Financial Results
... bleeding time. In a Phase II clinical trial and additional clinical pharmacology
studies completed in 2007, DG041 was shown to dramatically inhibit ... is building upon these successful results with a second clinical pharmacology
study of the effects of DG041 when taken with aspirin and Plavix(TM). ...
Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
... conducted with
ANA773 over the last 18 months has taught us much about the pharmacology
orally administered TLR7 agonists, including the importance of schedule ... ANA773 is an orally administered prodrug of a novel TLR7-specific
studies have shown that ANA773 can elicit desired
immune responses and ...
Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
... contributions to our management team."
Dr. Anderes earned a Ph.D. in pharmacology
from the Southern Illinois
University School of Medicine, and she performed a postdoctoral research
fellowship in pharmacology
at the University of California San Diego.
About Cylene Pharmaceuticals, ...
NeurogesX Expands Senior Management Team
... roles at Syntex Corporation. Ms. Rinne received a Master of Science
and Toxicology and a Bachelors of Science from the
University of ... at Xoma Corporation and Systemix Inc. Dr. Kawahata earned a
Ph.D. in pharmacology
and Environmental Toxicology from the University of
California, Davis and ...
EGEN, Inc. Announces the Promotion of Jason Fewell, Ph.D., to Vice-President of Preclinical Research and Development
... specializing in nucleic acid therapeutics and delivery, announced today that Jason Fewell, Ph.D., has been promoted from Director of Biology and pharmacology
to Vice-President of Preclinical Research and Development.
Dr. Fewell possesses more than 10 years management and scientific leadership ...
iCardiac Expands Sales and Marketing Team
... said Sasha Latypova, Executive Vice President. "Susan's deep client relationships and long history of successfully partnering with clinical pharmacology
units will allow iCardiac to better serve its rapidly broadening set of customers and channel relationships."
"I am proud to join ...
Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level
... its drug discovery collaboration with ELARA
Pharmaceuticals to a new level. ChemPartner will provide fully integrated
services in the areas of DMPK, pharmacology
and toxicology for ELARA's lead
oncology programs. Members of the joint project team from both sides will
work closely together to design and ...
Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing
... Chris Kendrick-Parker , chief commercial officer of CDI. "That is the primary requirement for commercial application of these cells as tools in the pharmacology
and toxicity testing market. Similar to our recently announced in-licensed patent portfolio from Mount Sinai School of Medicine, the IUPUI ...
Brazil's Scientific Research On The Rise, Thomson Reuters Study Finds
... 3.2 percentage points between the 1994-1998 period and the 2004-2008 period. Plant & animal sciences ranked second with a 3 percent increase and pharmacology
& toxicology rounded out the top three with a 1.78 percent increase.
Science Watch also assessed the overall impact of Brazil's ...
AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction
... Zentaris, emerged from an international collaboration between the research groups of Prof. Suzanne Dickson and Prof. Jörgen Engel who performed the pharmacology
work at the Sahlgrenska Academy, Gothenburg, Sweden, and the research group of Prof. Jean Martinez who synthesized the tested compound AEZS-123 at ...
Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
... to the success of the first phase. This next phase moves the companies toward assessing iPSC-derived cardiomyocytes as a cardiovascular safety pharmacology
as well as toxicology tool.
iPSCs are adult tissue cells that have been reprogrammed to a pluripotent, embryonic-like state. Like embryonic ...
Cordex Completes Production of ATPace(TM) Clinical Trial Material
About Cordex Pharma , Inc.
Cordex is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology
of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the ...
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
... including the remaining GMP scale-up production activities, the outcome of its upcoming pre-IND meeting and the outcome of the remaining non-clinical pharmacology
and toxicology studies will ultimately determine the timing of Helix's Phase I/II IND/CTA filings.
Topical Interferon Alpha-2b Product ...
Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
... the potential to become an important new treatment for patients with SLE," said Joan T. Merrill, M.D., a study investigator, Program Chair, Clinical pharmacology
Research Program, Oklahoma Medical Research Foundation, Oklahoma City, and Professor, Department of Medicine, University of Oklahoma Health Sciences ...
PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
... Rio Grande, Puerto Rico
Bengt Danielsson, MD, PhD, Vice President, PharmaNet Consulting,
will present "Exaggerated pharmacology
Versus True Toxicity."
Dr. Danielsson's presentation is part of the International Life
Sciences Institute and the Health ...
HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University
... and screening of novel pharmaceutical compounds, pharmaceutical formulation development and evaluation, pharmacokinetics and pharmacodynamics, pharmacology
and toxicology, and identification and purification of active ingredients from Traditional Chinese Medicines and natural products.